Clinical Trials Directory

Trials / Completed

CompletedNCT04642274

The Impact of ERAS Program in Cardiac Surgery on Patient Prognosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
400 (actual)
Sponsor
Shanghai Zhongshan Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to develop, verify and optimize the ERAS protocol for cardiac surgery.

Detailed description

The aim of the study is to develop, verify and optimize the ERAS protocol for cardiac surgery, thereby improving the overall prognosis of cardiac surgery patients, reducing the incidence of complications, and shortening the length of hospital stay.

Conditions

Interventions

TypeNameDescription
OTHERPreoperative StrategiesPatient Education Preoperative Oral Carbohydrate Loading Nutritional Optimization Glycemic Control Anemia Correction Preoperative Hair Removal
OTHERIntraoperative StrategiesAnesthetic Technique (Multimodal Analgesia) Antibiotics Glycemic Control Blood Transfusion Blood Conservation Optimization of Hemodynamics Protective Lung Ventilation Strategy Optimization of Anesthetic Depth Optimization of CPB Management
OTHERPostoperative StrategiesPostoperative Analgesia Temperature Management Renal Protection Glycemic Control Early Extubation Early Oral Intake Maintain Drain Patency and Early Removal Early Ambulation Thromboprophylaxis

Timeline

Start date
2021-07-01
Primary completion
2023-06-30
Completion
2023-11-30
First posted
2020-11-24
Last updated
2025-08-03

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04642274. Inclusion in this directory is not an endorsement.